Table S1. Oligonucleotide primer sequences

Similar documents
Revised: RG-RV2 by Fukuhara et al.

Percent survival. Supplementary fig. S3 A.

Supplemental Table S1. RT-PCR primers used in this study

Nature Immunology: doi: /ni Supplementary Figure 1. Zranb1 gene targeting.

(A-B) P2ry14 expression was assessed by (A) genotyping (upper arrow: WT; lower

LRBA is Essential for Allogeneic Responses in Bone Marrow Transplantation

Supplementary Methods

Supplementary Figures and Figure legends

SUPPLEMENTARY INFORMATION

Supplementary Figure 1. Xbp1 deficiency does not alter hematopoietic cellularity.

Tumour 2. Tumour 9. Tumour 25 Tumour 26. Tumour 27. t(6;16) doi: /nature06159 SUPPLEMENTARY INFORMATION Supplementary Figure 1

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

Generation of App knock-in mice reveals deletion mutations protective against Alzheimer s. disease-like pathology. Nagata et al.

PrimePCR Assay Validation Report

Supporting Information

Nature Immunology: doi: /ni.3694

Supplementary Figure 1. Characterization of the POP2 transcriptional and post-transcriptional regulatory elements. (A) POP2 nucleotide sequence

Development of CD11b-IRF8 transgenic and MTAG double transgenic mice The CMV-

SUPPLEMENTARY INFORMATION

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

We designed the targeting vector in such a way that the first exon was flanked by two LoxP sites and

SUPPLEMENTARY INFORMATION

PrimePCR Assay Validation Report

Supplemental Figure 1

SUPPLEMENTARY INFORMATION

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

Fig. S1. eif6 expression in HEK293 transfected with shrna against eif6 or pcmv-eif6 vector.

PrimePCR Assay Validation Report

Nature Biotechnology: doi: /nbt Supplementary Figure 1. In vitro validation of OTC sgrnas and donor template.

Supplementary Data. Flvcr1a TCTAAGGCCCAGTAGGACCC GGCCTCAACTGCCTGGGAGC AGAGGGCAACCTCGGTGTCC

Materials and Methods

Supplemental Information. Inflammatory Ly6C high Monocytes Protect. against Candidiasis through IL-15-Driven. NK Cell/Neutrophil Activation

Nature Immunology: doi: /ni Supplementary Figure 1

PrimePCR Assay Validation Report

Figure S Relative MUC4 transcript level* CD18/HPAF CD18/HPAF-Scr CD18/HPAF-siMUC4

PrimePCR Assay Validation Report

Nature Immunology: doi: /ni Supplementary Figure 1

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

Nature Immunology: doi: /ni Supplementary Figure 1. Construction of lnckdm2b RFP reporter and lnckdm2b-knockout mice.

Supplementary Materials for

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

Supplementary Table S1

PrimePCR Assay Validation Report

Who pairs with whom? High-throughput sequencing of the human paired heavy and light chain repertoire

a Lamtor1 (gene) b Lamtor1 (mrna) c WT Lamtor1 Lamtor1 flox Lamtor2 A.U. p = LysM-Cre Lamtor3 Lamtor4 Lamtor5 BMDMs: Φ WT Φ KO β-actin WT BMDMs

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

Student Learning Outcomes (SLOS)

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

Supplementary Figure S1: (A) Schematic representation of the Jarid2 Flox/Flox

PrimePCR Assay Validation Report

Supplemental Information

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

Receptor Revision Diminishes the Autoreactive B Cell Response after Antigen. PNA Tet. Day 8. Day 16

PrimePCR Assay Validation Report

Supplementary Material & Methods

Recombination Lecture, Dr. Aguilera 2/17/2014

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

SUPPLEMENTARY DATA. Table S1 Clinical features of new SS/MF patients enrolled in SNP6.0 and 10K analysis. % of TCRVß+ within CD3+CD4+

amplify the conditional allele (2-lox) and recombined allele (1-lox) following tamoxifen


PrimePCR Assay Validation Report

Supporting Information

Supplementary Fig. 1: Characterization of Asxl2 -/- mouse model. (a) HSCs and their

Supplementary Figure 1 An overview of pirna biogenesis during fetal mouse reprogramming. (a) (b)

PrimePCR Assay Validation Report

PrimePCR Assay Validation Report

embryos. Asterisk represents loss of or reduced expression. Brackets represent

A novel tool for monitoring endogenous alpha-synuclein transcription by NanoLuciferase

SUPPLEMENTAL MATERIAL

Table S1. Primers used in the study

HC70AL SUMMER 2014 PROFESSOR BOB GOLDBERG Gene Annotation Worksheet

WT Day 90 after injections

administration of tamoxifen. Bars show mean ± s.e.m (n=10-11). P-value was determined by

Rassf1a -/- Sav1 +/- mice. Supplementary Figures:

Supplemental Materials. Matrix Proteases Contribute to Progression of Pelvic Organ Prolapse in Mice and Humans

Somatic Primary pirna Biogenesis Driven by cis-acting RNA Elements and Trans-Acting Yb

Supplementary Figure 1 Generation of migg1-yf mice. (A) Targeting strategy. Upper panel: schematic organization of the murine ɣ1 immunoglobulin

Relative Quantification: Data Management & Analysis Settings

4 Themes in B cell development + Ig class switch and somatic mutation Tony DeFranco, 10/28/13 Checkpoints in B cell development: feedback from Ig

File name: Supplementary Information Description: Supplementary figures and supplementary tables. File name: Peer review file Description:

Pei et al. Supplementary Figure S1

A Low salt diet. C Low salt diet + mf4-31c1 3. D High salt diet + mf4-31c1 3. B High salt diet

C57BL/6N Female. C57BL/6N Male. Prl2 WT Allele. Prl2 Targeted Allele **** **** WT Het KO PRL bp. 230 bp CNX. C57BL/6N Male 30.

BS 50 Genetics and Genomics Week of Oct 24

Ramp1 EPD0843_4_B11. EUCOMM/KOMP-CSD Knockout-First Genotyping

Transcription:

Table S1. Oligonucleotide primer sequences Primer Name DNA Sequence (5 -> 3 ) Description CD19c CD19d Cre7 Sfpi1lox1 Sfpi1lox2 Sfpi1lox3 5 -AACCAGTCAACACCCTTCC-3 5 -CCAGACTAGATACAGACCAG-3 5 -TCAGCTACACCAGAGACGG-3 5 -CTTCACTGCCCATTCATTGGCTCATCA-3 5 -GCTGGGGACAAGGTTTGATAAGGGAA-3 5 -CAACCGGATCTAGACTCGAGGA-3 CD19 Cre genotyping CD19c+CD19d product size: 452 bp (wild type allele); CD19c + Cre7 product size: ~700 bp (knockin allele) Sfpi1 lox genotyping wild type product 395 bp; lox allele product size: 533 bp. Spib forward Spib reverse PGK reverse sfpi1 exon 34 forward sfpi1 exon 34 reverse 5' -GGGCTCCTTGGCTTATGCTCC -3' 5' CGCGCTGTCAAACTGGTAGGT-3' 5 -CAGAAAGCGAAGGAGCAAAGCTG-3 5 -CGAGTTTGAGAACCTCCCTGAGAACCAC -3 5 - GGACAAGGTTTGATAAGGGAAGCACATCCG - 3 Spib - genotyping Wild type product 950 bp; knockout allele product size: 1100 bp Primer pair to amplify intron between Sfpi1 exons 3 and 4 Product size: 995 bp spfi1 exon 5 5 - AGACAGGCGAGGTGAAGAAAGTCA -3 forward spfi1 exon 5 reverse 5 - GGCACACACATGGCACACATACAT -3 Primer pair to amplify between Sfpi1 exons 5 and 3 UTR Product size: 1667 bp front internal sequencing end internal sequencing 5 - TCAAGAGTTTGCGTGTGCCG -3 Sequencing primer for Sfpi1 exons 3 to 4 PCR product 5 - CCTCAGGAAACACAAACCC -3 Sequencing primer for Sfpi1 exon 5 to 3 UTR product lox-exon4 forward 5 - ATGATCGGAATTCCTCGACGGT -3 qpcr primers to detect intact Sfpi1 lox allele frequency lox-exon4 reverse 5 - TTCCAACTGTGGCCTCTGGTTT -3 Product size: 85 bp cko1 5 - CTTCACTGCCCATTCATTGGCTCATCA -3 cko2 5 - CAACCGGATCTAGACTCGAGGA -3 qpcr primers to detect deleted Sfpi1 lox allele (Sfpi1Δ) frequency Product size: 298 bp

β-actin promoter fwd β-actin promoter rev 5 -CCCCGCGTGTCCCTC-3 5 -AACCACCCCAGGACCCTC-3 qpcr primers to detect intact β- actin promoter gene frequency Product size: 122 bp RT-q PCR primers Gapdh fwd 5 -GAACATCATCCCTGCATCCA-3 Gapdh rev 5 -CCAGTGAGCTTCCCGTTCA-3 Product size: 78 bp IL7αR fwd 5 -ACGATCACTCCTTCTGGTGC -3 IL7αR rev 5 - GCATTTCACTCGTAAAAGAGCC-3 Product size: 140 bp VpreB1fwd 5 -ACGTCTGTCCTGCTCATGCT-3 VpreB1 rev 5 -TGTTATGGTCGTTGCTCAGG-3 Product size: 136 bp CD23 fwd 5 - TGGCTCCATTTCCAACAGAAGTGC-3 CD23 rev 5 - ATTGAGATCCTGGAGGCCAATCCA-3 Product size: 183 bp CD19 fwd 5 -ACCAGTTGGCAGGATGATGGACTT -3 CD19 rev 5 -TTCATGACTGGGACCGGACTGAAT -3 Product size: 160 bp Pax5 fwd 5 -CGGGTCAGCCATGGTTGTG -3 Pax5 rev 5 -GTGCTGTCTCTCAAACACG-3 Product size: 561 bp Btk fwd 5 -GCTCTGTAGGCTCCAAGTTTC -3 Btk rev 5 -ATCTCTCATACGGCATCTTCC-3 Product size: 144 bp Blnk fwd 5 -TCCAAGTCATCTTTGCCTGCC -3 Blnk rev 5 -TGCATTCGGTACGGGAGGAAC -3 Product size: 102 bp E12 fwd 5 -GGGAGGAGAAAGAGGATGA -3 E12 rev 5 -GCTCCGCCTTCTGCTCTG-3 Product size: 138 bp E47 rev 5 -CCGGTCCCTCAGGTCCTTC-3 Combined with E12 fwd. Product size: 138 bp Id2 fwd 5 -CACAGAGTACTTTGCTATCATTCG-3 Id2 rev 5 -CCTGAACACGGACATCAGC-3 Product size: 83 bp Id3 fwd 5 -CACTTACCCTGAACTCAACGCC-3 Id3 rev 5 -CCCATTCTCGGAAAAGCCAG-3 Product size: 160 bp

Figure S1. Analysis of gene expression in sorted follicular B cells (A) Changes in frequencies of mrna transcripts in FO B cells lacking Spi-B or both PU.1 and Spi-B. Cell sorting was used to enrich B220 + CD93 IgM + CD23 + follicular (FO) B cells from the spleen of 9-week old Wild Type, CD19 + + Sfpi1 lox lox Spib, or CD 19+/Cre Sfpi1 lox lox Spib mice. Gating was performed as shown in Fig. 1D, upper panels. RNA was prepared from each sample and RT-qPCR used to measure relative frequencies of steady-state mrna transcript levels for genes indicated on the x-axis. Transcript frequencies were normalized to Gapdh transcript levels. The y-axis represents fold change in transcripts in CD19 + + Sfpi1 lox lox Spib FO B cells or CD19 +/Cre Sfpi1 lox lox Spib FO B cells relative to Wild Type FO B cells. (B) Changes in frequencies of mrna transcripts in Sfpi1 + Spib FO B cells. Cell sorting was used to enrich (FO) B cells from the spleen of 9-week old Wild Type or Sfpi1 + Spib (PUB) mice as described above. The y-axis represents fold change in transcripts in Sfpi1 + Spib FO B cells relative to Wild Type FO B cells. Figure S2. Blastic lymphocytes are present in spleen, lymph node, bone marrow, and blood of moribund CD19 +/Cre Sfpi1 lox lox Spib mice (A) Histology of the spleen in moribund CD19 +/Cre Sfpi1 lox lox Spib mice (original magnification, 60 ). (B) Histology of an enlarged lymph node in moribund CD19 +/Cre Sfpi1 lox lox Spib mice (original magnification, 60 ). (C) Histology of the bone marrow in moribund CD19 +/Cre Sfpi1 lox lox Spib mice (original magnification, 60 ) (D) Elevated lymphocyte counts in the blood of 18-20 week old CD19 +/Cre Sfpi1 lox lox Spib mice. Complete blood cell counts were performed on mice of the indicated genotypes. A legend is provided on the right; EO, eosinophils; MO, monocytes; LY, lymphocytes; NE, neutrophils. Basophils were counted but are not shown (<50/µl).

Figure S3. High frequency of pre-b cells in the thymus, spleen, and lymph node of moribund CD19 +/Cre Sfpi1 lox/lox Spib -/- mice. (A) High frequency of pre-b cells in the thymus of a 24-week old CD19 +/Cre Sfpi1 lox/lox Spib -/- mouse. Flow cytometric analysis was used to analyze expression of cell surface CD4, CD8, CD19, and B220 on thymocytes from a 6-week old C57Bl/6 mouse as a control (left panels) or a 24-week old CD19 +/Cre Sfpi1 lox/lox Spib -/- mouse (right panels). (B) Pre-B cells in the thymus of CD19 +/Cre Sfpi1 lox/lox Spib -/- mice express CD44, BP-1, and low levels of CD45. Flow cytometric analysis was used to analyze expression of cell surface CD19, CD44, BP-1, and CD45.2 on thymocytes from a 20-week old CD19 +/+ Sfpi1 lox/lox Spib -/- mouse (left panels) or a CD19 +/Cre Sfpi1 lox/lox Spib -/- mouse (right panels). (C) High frequency of pre-b cells in the spleen of 24-week old CD19 +/Cre Sfpi1 lox/lox Spib -/- mice. Flow cytometric analysis was used to analyze expression of cell surface CD19, B220, and CD93 on splenocytes from a 6-week old C57Bl/6 mouse (left panels) or a 24-week old CD19 +/Cre Sfpi1 lox/lox Spib -/- mouse (right panels). (D) High frequency of pre-b cells in an enlarged lymph node of a 24-week old CD19 +/Cre Sfpi1 lox/lox Spib -/- mouse. Flow cytometric analysis was used to analyze expression of cell surface CD19, B220, and CD93 on cells from the enlarged lymph node of a 24-week old CD19 +/Cre Sfpi1 lox/lox Spib -/- mouse.